AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Life Sciences Executive Mark J. Stevens Joins Navigant as a Managing Director

April 2, 2019

CHICAGO--(BUSINESS WIRE)--Apr 2, 2019--Life sciences and pharmaceutical professional Mark J. Stevens has joined Navigant (NYSE: NCI) as a managing director in its life sciences practice.

Stevens will help lead Navigant’s global life sciences strategy consulting and data analytics team, and assist with creating centers of excellence focusing on patient services, operations, and pharmacovigilance. He brings more than 20 years of large and small pharmaceutical company experience leading strategy, operations, marketing, and sales analytics and technology.

According to Eduardo Schur, managing director and leader of Navigant’s global life sciences practice, “The complexity of the global life sciences market continues to accelerate. Mark will work with some of the largest pharmaceutical and medical device organizations around the world to build insightful and value-based solutions supporting planning, strategy, and execution. We’re thrilled to have him on board.”

Stevens previously served as chief strategy officer at Publicis Health, where he was responsible for the development and execution of strategic initiatives in all program areas of Publicis Health Solutions. He also served in multiple leadership roles in commercial effectiveness at Novartis, Bristol Myers Squibb, Sanofi, and Schering Plough. Stevens holds a Master of Science in management systems with specialization in advanced analytics from Clarkson University, and an MBA with specialization in marketing and a Bachelor of Science in biology from University of Madras.

Navigant’s life sciences practice is comprised of specialized consultants, former pharmaceutical and medical technology executives, clinicians, and other experts with decades of strategy, operational consulting, compliance, regulatory, and reimbursement services experience. Professionals collaborate with life sciences clients, as well as hospitals and health systems, physician enterprises, payers, and government, to provide strategic management solutions. Navigant’s life sciences practice is a part of the firm’s healthcare segment.

About Navigant

Navigant Consulting, Inc. (NYSE: NCI) is a specialized, global professional services firm that helps clients take control of their future. Navigant’s professionals apply deep industry knowledge, substantive technical expertise, and an enterprising approach to help clients build, manage, and/or protect their business interests. With a focus on markets and clients facing transformational change and significant regulatory or legal pressures, the firm primarily serves clients in the healthcare, energy, and financial services industries. Across a range of advisory, consulting, outsourcing, and technology/analytics services, Navigant’s practitioners bring sharp insight that pinpoints opportunities and delivers powerful results. More information about Navigant can be found at navigant.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190402005114/en/

CONTACT: Kyle Bland

Navigant Investor Relations

312.573.5624

kyle.bland@navigant.com

Alven Weil

Navigant

704.995.5607

alven.weil@navigant.com

KEYWORD: UNITED STATES NORTH AMERICA ILLINOIS

INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT HEALTH MEDICAL DEVICES PHARMACEUTICAL PROFESSIONAL SERVICES CONSULTING LEGAL OTHER PROFESSIONAL SERVICES

SOURCE: Navigant

Copyright Business Wire 2019.

PUB: 04/02/2019 07:00 AM/DISC: 04/02/2019 07:00 AM

http://www.businesswire.com/news/home/20190402005114/en